Skip to content

ADM opens new R&D center at Biopôle to advance animal microbiome science

Life sciences

30 June 2025

ADM is strengthening its innovation footprint in Western Switzerland with a new R&D center focused on microbiomes to support animal health. The center is located at the Biopôle in Lausanne. ADM is a global leader in animal and human nutrition, developing science-based solutions to support health, sustainability, and performance. | © ADM

ADM is strengthening its innovation footprint in Western Switzerland with a new R&D center focused on microbiomes to support animal health. The center is located at the Biopôle in Lausanne.

ADM has announced the opening of a new research and development center dedicated to animal microbiome research at the Biopôle life sciences campus in Lausanne. This 1,600-square-meter facility will focus on the development of biotics and fermentation-derived ingredients designed to support the health and well-being of pets, livestock, and aquaculture species.

The new R&D center strengthens ADM’s presence in Western Switzerland, following the 2021 launch of its animal nutrition laboratory in Rolle. While the Rolle site focuses on the development of feed additives to optimize animal performance, the new facility at Biopôle deepens the company’s commitment to innovation in health and wellness through targeted microbiome research.

ADM’s scientists will conduct pre-clinical studies to better understand the role of the gut microbiome in immune, digestive, and metabolic functions. These insights will help formulate next-generation pre-, pro-, and postbiotic solutions adapted to both companion animals and farm species.

Driving animal wellness through microbiome innovation

“We are proud to launch this state-of-the-art center, uniquely dedicated to microbiome research for pet and farm animal health and wellness,” said Dr. Nuria Miquel, Senior Vice President and Chief Science Officer at ADM. “It represents a significant step forward in our purpose to advance animal wellness through science and innovation.”

The global market for biotics in animal feed was valued at USD 5.2 billion in 2024 and continues to grow as demand rises for functional ingredients that improve productivity and animal health. ADM’s research supports a shift away from antibiotics and toward science-based alternatives, in line with broader sustainability and welfare goals.

For companion animals, microbiome solutions are increasingly in demand. A recent ADM global survey found that 84% of pet owners are interested in products that support longevity and vitality in their pets.